Birlasoft Limited will hold two group meetings with analysts and institutional investors in Mumbai over August 13 and 14, 2026. The company disclosed the schedule to the stock exchanges pursuant to the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, ensuring transparency regarding its engagement with market participants.

The meetings are scheduled as part of broader investor conferences. The first session will take place at the Emkay Confluence event at 2 pm on August 13, 2026. The second session is set for 1 pm on August 14, 2026, during the Equirus Annual India Conference. Both events will be conducted as physical meetings in Mumbai.

Sneha Padve, Company Secretary & Compliance Officer of Birlasoft Limited, signed the disclosure filed with BSE Limited and National Stock Exchange of India Ltd. on August 10, 2026. The filing explicitly states that no Unpublished Price Sensitive Information (UPSI) will be shared during these interactions.

The company noted that the date and time of the meetings are subject to change due to exigencies on the part of either the investors or the company. Investors are advised to monitor official communications for any updates regarding the schedule.

Birlasoft Ltd reported a robust start to FY27, with net profit after tax (PAT) surging 51.3% year-on-year to ₹1,610 Mn in Q1FY27. The profit growth was underpinned by a significant expansion in operating margins and improved working capital management, signaling strong operational efficiency despite flat dollar revenue. Cash reserves strengthened by 26% YoY to ₹28,786 Mn. The company filed its unaudited consolidated financial results for the quarter ended June 30, 2026, with the BSE and NSE on July 28, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

Revenue from operations grew 7.4% year-on-year to ₹13,794 Mn, driven by sequential growth of 2.3%. In dollar terms, revenue was relatively flat at $145.2 Mn, down 0.1% quarter-on-quarter but up 0.3% in constant currency terms. The BFSI and Lifesciences & Services (LSS) verticals led the growth, offsetting weakness in Manufacturing and Energy & Utilities (E&U).

While EBITDA declined 10.6% sequentially to ₹2,228 Mn due to revenue normalization post-Q4 seasonality, the margin remained healthy at 16.1%, expanding significantly by 379 basis points compared to Q1FY26. CEO Angan Guha noted that this margin is closer to the company's sustainable range, excluding one-off items from the previous quarter. CFO Chandrasekar Thyagarajan highlighted that the effective tax rate settled at 29.4%, closer to historical levels after transitional US federal tax provisions in FY26.

Operational Highlights & Deal Wins

Deal signings during the quarter totaled $169 Mn in total contract value (TCV), representing a 20% year-on-year increase from $141 Mn in Q1FY26. These wins included several AI-led engagements, such as a strategic partnership with a leading US-based financial services player and a Gen AI contract with a large P&C insurer. In Europe, Birlasoft won a multiyear deal with a leading banking group for AI-led transformation. In LSS, it secured a strategic engagement with a global pharma company for Gen AI-powered pharmacovigilance solutions.

Working capital metrics showed marked improvement. Days Sales Outstanding (DSO) reduced to 55 days from 62 days in Q4FY26, reflecting strong collections of $163.1 Mn. Cash and cash equivalents stood at $304.1 Mn (₹28,786 Mn), up 9% quarter-on-quarter. Workforce strength decreased slightly to 11,057 employees, with attrition falling to 11.7% from 13.0% in the previous quarter.

What the Numbers Show

The divergence between flat dollar revenue and surging rupee profitability highlights the impact of currency movements and margin optimization. While top-line growth in USD terms was negligible (-0.1% QoQ), the expansion in EBITDA margin by nearly 400 basis points YoY demonstrates that Birlasoft is successfully monetizing its higher-value AI and digital engineering services. The improvement in DSO alongside rising cash balances indicates effective liquidity management, reducing reliance on external funding despite ongoing investments in tech capabilities.

Outlook and Strategic Focus

Management indicated that wage increases effective July 1, 2026, could dilute margins by 170–200 basis points in Q2FY27, though productivity improvements are expected to offset half of this impact. Angan Guha stated that Financial Services and LSS demand will remain strong, while Manufacturing and E&U are expected to turn around from Q3FY27 onwards. The company is expanding its sales team to drive organic growth, with H1FY27 deal signings expected to be better than H1FY26. On capital allocation, the Board plans to reward shareholders while maintaining balance sheet strength for potential capability-based inorganic growth.